Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial

NCT00370851 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Retinal Disease

Interventions

DRUG: Avastin (Bevacizumab)

Sponsor

Shahid Beheshti University of Medical Sciences